ArticleBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025
[Further education and training of German pharmacists].
Article in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2013 amending directive on the recognition of professional qualifications (2005/36/EC) calls on European countries to implement concepts for the continuing professional development of healthcare professionals. This article examines the development of continuing education and training of pharmacists in Germany and compares it with Austria, France, Switzerland and the UK.The development of a voluntary training certificate for pharmacists in Germany began in the early 2000s. The certificate requires proof of 150 continuing education points, which can be earned by attending lectures, seminars and other educational activities, to be submitted to the responsible chamber of pharmacists. With the introduction of pharmaceutical services and vaccinations in 2022, proof of specific qualification measures will be linked to the authorisation to provide certain services.Specialisation developed differently in the German Democratic Republic (GDR) and the Federal Republic of Germany (FRG). In the GDR, specialisation was possible from 1974 and in the FRG from 1979. Today, further training to become a specialist pharmacist is offered in 10 areas, and additional designations can be acquired in 8 areas. Many EU countries have mandatory continuing education requirements, which are usually monitored by a professional association. Austria introduced mandatory continuing education in 2024. In Switzerland, in addition to specialisation, regular proof of continuing education is also required to manage a community pharmacy. France and the UK have mandatory revalidation systems that go beyond this, with the UK having implemented continuous professional (competence) development most comprehensively. Germany has the opportunity to utilise the experience of other European countries in order to further develop its continuing education and specialisation in line with EU standards.
Indexed as
Identifiers
40146307What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.